TBPN cover image

$2B Allergy Drug, ChatGPT Ads, Mansion Section | Billy Boman, Benjamin Miller, Faris Sbahi, Evan Loomis, Anvisha Pai, Ryan Tseng

TBPN

00:00

Novartis Buys Its Allergy Drug Successor

John Coogan explains Novartis buying stealth biotech Accelergy for up to $2 billion and why it fits a proven biotech acquisition playbook.

Play episode from 01:46
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app